Thursday's Top Analyst Upgrades and Downgrades: Canopy Growth, Cleveland-Cliffs, Datadog, Electronic Arts, Palo Alto Networks, Peloton, Snowflake, SoFi and More

The futures traded lower on Thursday, after the Federal Reserve once again raised the federal funds rate by an expected 75 basis points. With the benchmark rate now 3.75% to 4.00% (which is the highest since 2008), many across Wall Street feel that we are within range of the terminal ending rate of 5%. All the major indexes closed lower Wednesday, after there was basically no pivot chatter whatsoever from Fed Chair Powell during his commentary. One thing seems to be a given: the lagging effect of interest rate increases may not be felt in full until next year.

Treasury rates were flat across the curve Wednesday, and it is possible that the day’s buying was short covering in an attempt to move the short positions out to a later date. The 10-year yield closed at 4.06%, which keeps the inversion with the two-year in place, as it closed Wednesday at 4.61%. The inversion’s spread has widened over the past few weeks.

After a big move higher Tuesday, both Brent and West Texas Intermediate crude followed through Wednesday, with both benchmarks tacking on close to 1% gains on the day. Prices moved higher intraday after the Energy Information Association reported an inventory draw for the period ending October 28 of 3.1 million barrels. Natural gas soared a massive 8.4% to close at $6.20. Gold and Bitcoin closed slightly lower on the day.

24/7 Wall St. reviews dozens of analyst research reports each day of the week with a goal of finding fresh ideas for investors and traders alike. Some of these daily analyst calls cover stocks to buy. Other calls cover stocks to sell or avoid. Remember that no single analyst call should ever be used as a basis to buy or sell a stock. Consensus analyst target data is from Refinitiv.

These are the top analyst upgrades, downgrades and initiations seen on Thursday, November 3, 2022.

Avista Corp. (NYSE: AVA): Mizuho downgraded the shares to Neutral from Buy and trimmed its $44 target price to $40. The consensus target is $39.50. Wednesday’s close was at $36.88.

BioCryst Pharmaceutical Inc. (NASDAQ: BCRX): Evercore ISI upgraded the shares to Outperform from In Line and bumped its $14 target price up to $16. The consensus target is $17.60. The last trade on Wednesday came at $12.02.

Boise Cascade Co. (NYSE: BCC): Goldman Sachs raised its price target on the Neutral-rated shares to $72 from $64. The consensus target is $70.80. Wednesday’s close at $63.57 was down close to 5% on the day.

Canopy Growth Corp. (NASDAQ: CGC): Bernstein initiated coverage on the weed stock with an Underperform rating and a $1.50 target price. The consensus target is higher at $5.97. The stock closed over 7% lower on Wednesday at $3.23.

Catalent Inc. (NYSE: CTLT): The BofA Securities downgrade was to Neutral from Buy, and it slashed its $125 target price to $60. The consensus target is $106.38 for now. Wednesday’s close at $44.90 was down over 9% after an earnings miss and a lowered outlook.

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.